Takeda Pharmaceutical
TAK
#378
Rank
A$94.95 B
Marketcap
A$29.72
Share price
4.50%
Change (1 day)
44.80%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): -A$46.21 Million

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are A$29.54 Billion. In 2025 the company made an earning of A$4.72 Billion, an increase over its 2024 earnings that were of A$3.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$46.21 Million-100.98%
2025 A$4.72 B49.03%
2024 A$3.17 B-2.41%
2023 A$3.25 B-28.14%
2022 A$4.52 B-40.9%
2021 A$7.65 B78.24%
2020 A$4.29 B246.1%
2019 A$1.24 B-48.79%
2018 A$2.42 B-23.64%
2017 A$3.17 B21.7%
2016 A$2.60 B-253.01%
2015 -A$1.71 Billion-159.65%
2014 A$2.85 B13%
2013 A$2.52 B2.46%
2012 A$2.46 B-57.05%
2011 A$5.74 B-10.49%
2010 A$6.41 B-3.99%
2009 A$6.68 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.25 B-21,333.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.06 B-12,675.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$9.81 B-5,695.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.62 B-8,434.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.17 B-5,901.19%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$10.93 B-6,330.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$11.21 B-6,491.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-A$1.13 Billion 540.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
A$0.71 B-507.73%๐Ÿ‡ฎ๐Ÿ‡ณ India